Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Johnson and Johnson
Daiichi Sankyo
US Department of Justice
Teva
US Army
Express Scripts
QuintilesIMS
Julphar

Generated: December 17, 2018

DrugPatentWatch Database Preview

MIDAZOLAM HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Midazolam Hydrochloride patents expire, and what generic alternatives are available?

Midazolam Hydrochloride is a drug marketed by Akorn Inc, Apothecon, Baxter Hlthcare Corp, Bedford, Ben Venue, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Hospira Inc, Igi Labs Inc, Intl Medicated, Intl Medication, West-ward Pharms Int, Wockhardt, Apotex Inc, Hi Tech Pharma, Paddock Llc, Sun Pharm Inds Ltd, and Mylan Asi. and is included in thirty-three NDAs.

The generic ingredient in MIDAZOLAM HYDROCHLORIDE is midazolam hydrochloride. There are nine drug master file entries for this compound. Twenty-three suppliers are listed for this compound. There are three tentative approvals for this compound. Additional details are available on the midazolam hydrochloride profile page.

Drug patent expirations by year for MIDAZOLAM HYDROCHLORIDE
Pharmacology for MIDAZOLAM HYDROCHLORIDE
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for MIDAZOLAM HYDROCHLORIDE
Synonyms for MIDAZOLAM HYDROCHLORIDE
3849AH
467M968
4H-Imidazo(1,5-a)(1,4)benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl-, hydrochloride
4H-Imidazo(1,5-a)(1,4)benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl-, monohydrochloride
4H-Imidazo[1,5a][1,4]benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl-, hydrochloride
59467-96-8
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine hydrochloride
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine monohydrochloride
8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine hydrochloride
8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine;hydrochloride
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5a][1,4]benzodiazepine hydrochloride
AC1L290O
AKOS024457308
Ambap59467-96-8
AN-39559
API0003386
C18H13ClFN3.ClH
C18H13ClFN3.HCl
CAS-59467-96-8
CCG-100983
CHEBI:6932
CHEMBL1200420
CPD000469160
CS-2908
D00696
Dormicum
DSSTox_CID_27824
DSSTox_GSID_47846
DSSTox_RID_82587
DTXSID8047846
EINECS 261-776-6
HSDB 6751
HY-B0676A
Hypnovel
Hypnovel hydrochloride
KB-74241
LS-77782
MFCD00864445
Midazolam (hydrochloride)
Midazolam Hcl
Midazolam hydrochloride (USAN)
Midazolam hydrochloride [USAN]
Midazolam hydrochloride preservative free
MLS001401415
NC00233
NCGC00168254-01
NCGC00168254-02
NSC-751451
NSC751451
Ro 21-3981/001
Ro 21-3981/003
Ro-213981-003
Ro-213981003
Rocam
SAM001246585
SC-47268
SCHEMBL41265
SMR000469160
TL8003788
Tox21_112613
Tox21_112613_1
UNII-W7TTW573JJ
Versed (TN)
Versed hydrochloride
W7TTW573JJ

US Patents and Regulatory Information for MIDAZOLAM HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wockhardt MIDAZOLAM HYDROCHLORIDE midazolam hydrochloride INJECTABLE;INJECTION 078511-002 Nov 10, 2008 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
West-ward Pharms Int MIDAZOLAM HYDROCHLORIDE midazolam hydrochloride INJECTABLE;INJECTION 075324-001 Jun 20, 2000 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE midazolam hydrochloride INJECTABLE;INJECTION 075857-001 Jul 22, 2002 AP RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharm Inds Ltd MIDAZOLAM HYDROCHLORIDE midazolam hydrochloride SYRUP;ORAL 076058-001 Mar 15, 2002 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE midazolam hydrochloride INJECTABLE;INJECTION 075857-002 Jul 22, 2002 AP RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Johnson and Johnson
Daiichi Sankyo
US Department of Justice
Teva
US Army
Express Scripts
QuintilesIMS
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.